News and Views

What the Evidence Says About Traditional Chinese Medicine for Chronic Diarrhea

Diarrhea is a distressing condition that significantly affects patients’ quality of life and social functioning. Characterized by passage of more than three unformed stools in 24 hours, in cancer it can be caused by chemotherapy, radiotherapy, laxatives and antibiotics, enteral feeding, malabsorption syndromes, colectomy, or several types of malignant tumors. Diarrhea has also been reported in long-term cancer survivors. Standard treatment options such as opiate agonists and adsorbents are associated with side effects that may increase a patient’s symptom burden.

Trending Topics

View All Topics

ONS Bridge™ Returns in September With Live and On-Demand Content for Oncology Nurses

ONS Bridge™ Returns in September With Live and On-Demand Content for Oncology Nurses

FDA Approves Crizotinib for Anaplastic Lymphoma Kinase-Positive Inflammatory Myofibroblastic Tumor

U.S. Food and Drug Administration (FDA)

FDA Approves Crizotinib for Anaplastic Lymphoma Kinase-Positive Inflammatory Myofibroblastic Tumor

Oncology Care Model Created New Opportunities for APRNs to Transform Cancer Care

Care coordination

Oncology Care Model Created New Opportunities for APRNs to Transform Cancer Care

Females Are More Likely to Have Severe Cancer Side Effects Than Males

Cancer research

Females Are More Likely to Have Severe Cancer Side Effects Than Males

Nurses Use Innovation to Perform Symptom and Pain Assessments

Symptom management

Nurses Use Innovation to Perform Symptom and Pain Assessments

Oncology Nursing QI Project Shows Normal Saline Is Comparable to Heparin for Pediatric CVCs

Oncology Nursing QI Project Shows Normal Saline Is Comparable to Heparin for Pediatric CVCs

Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 1

Genetics & genomics

Genetic Disorder Reference Sheet: Multiple Endocrine Neoplasia Type 1

FDA Warns About Risk of Death and Serious Side Effects With Duvelisib

U.S. Food and Drug Administration (FDA)

FDA Warns About Risk of Death and Serious Side Effects With Duvelisib

CNS Survivorship Needs More Research, Funding, and Training, Expert Panel Says

Cancer research

CNS Survivorship Needs More Research, Funding, and Training, Expert Panel Says

The Clinical Pharmacist’s Role in Symptom Assessments

Symptom management

The Clinical Pharmacist’s Role in Symptom Assessments

Symptom Assessment

Symptom management

Symptom Assessment

Journeying Through Life With ONS

Journeying Through Life With ONS

FDA Reports Recall of Morphine Sulfate Extended-Release Tablets Because of Label Mix-Up

U.S. Food and Drug Administration (FDA)

FDA Reports Recall of Morphine Sulfate Extended-Release Tablets Because of Label Mix-Up

FDA Approves Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma

Self-Affirmations Build Your Personal and Moral Resiliency

Nurse well-being

Self-Affirmations Build Your Personal and Moral Resiliency

ONS Board Releases Statement About Dobbs v. Jackson

ONS Board Releases Statement About Dobbs v. Jackson

Support Patients’ Autonomy and Cultural Choices

Ethics in nursing

Support Patients’ Autonomy and Cultural Choices

FDA Reports BD’s Recall of Intraosseous Products

U.S. Food and Drug Administration (FDA)

FDA Reports BD’s Recall of Intraosseous Products

FDA Says It’s Continuing to Evaluate Pulse Oximeters’ Race-Related Accuracy and Limitations

U.S. Food and Drug Administration (FDA)

FDA Says It’s Continuing to Evaluate Pulse Oximeters’ Race-Related Accuracy and Limitations

Genomics’ Red Flag Rule of Too and Two

Genetics & genomics

Genomics’ Red Flag Rule of Too and Two

ONS’s Clinical Decision Support Tool Brings Biomarker Advancements to the Point of Care

ONS’s Clinical Decision Support Tool Brings Biomarker Advancements to the Point of Care

male patient holding his head in his hands

Cancer research

Use of Anxiety and Depression Drugs Linked to Increased PSA Testing

Oncology Drug Reference Sheet: Loncastuximab Tesirine-Lpyl

Drug Reference Sheet

Oncology Drug Reference Sheet: Loncastuximab Tesirine-Lpyl

Digital Health Literacy Affects Overall Survival in Adults With Cancer

Cancer research

Digital Health Literacy Affects Overall Survival in Adults With Cancer

Margaret Hansen Frogge Receives 2022 Lifetime Achievement Award at 47th Annual ONS Congress

Margaret Hansen Frogge Receives 2022 Lifetime Achievement Award at 47th Annual ONS Congress

Catherine Lyons Posthumously Receives 2022 Lifetime Achievement Award at 47th Annual ONS Congress

Catherine Lyons Posthumously Receives 2022 Lifetime Achievement Award at 47th Annual ONS Congress

Maintain Oral Adherence With ONS Guidelines™

Maintain Oral Adherence With ONS Guidelines™

Pediatric Patients With Cancer Are Vulnerable to Sleep Disturbance

Patient quality of life

Pediatric Patients With Cancer Are Vulnerable to Sleep Disturbance

FDA Reports Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide/Aluminum Hydroxide/Simethicone Oral Suspension

U.S. Food and Drug Administration (FDA)

FDA Reports Recall of Milk of Magnesia Oral Suspension and Magnesium Hydroxide/Aluminum Hydroxide/Simethicone Oral Suspension

Independent Advocates Help Patients With Dementia Navigate Cancer Care

Care coordination

Independent Advocates Help Patients With Dementia Navigate Cancer Care

Erica Fischer-Cartlidge, DNP, CNS, AOCNS®, EBP-C

ONS Hires Erica Fischer-Cartlidge, DNP, CNS, AOCNS®, EBP-C, as Chief Clinical Officer

Childhood Cancer Survivors Have Healthy but Riskier Pregnancies

Cancer research

Childhood Cancer Survivors Have Healthy but Riskier Pregnancies

Special Populations

Cancer health disparities

Special Populations

Collaborations Advance ONS’s Goals and Innovation

Collaborations Advance ONS’s Goals and Innovation

FDA Reports Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks

U.S. Food and Drug Administration (FDA)

FDA Reports Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks

FDA Withdraws Approval of Umbralisib Because of Safety Concerns

U.S. Food and Drug Administration (FDA)

FDA Withdraws Approval of Umbralisib Because of Safety Concerns

$FDA Approves Tisagenlecleucel for Relapsed or Refractory Follicular Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Approves Tisagenlecleucel for Relapsed or Refractory Follicular Lymphoma

FDA Approves Nivolumab in Combination With Chemotherapy and in Combination With Ipilimumab for First-Line Esophageal Squamous Cell Carcinoma Indications

U.S. Food and Drug Administration (FDA)

FDA Approves Nivolumab in Combination With Chemotherapy and in Combination With Ipilimumab for First-Line Esophageal Squamous Cell Carcinoma Indications

Naive T-Cell Depletion Prevents Chronic GVHD in Transplantation Survivors

Cancer research

Naive T-Cell Depletion Prevents Chronic GVHD in Transplantation Survivors

Rest, Unwind, and Reflect so You Can Lead by Example

Nurse well-being

Rest, Unwind, and Reflect so You Can Lead by Example

FDA Approves Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

U.S. Food and Drug Administration (FDA)

FDA Approves Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

Spring Clean Your Home and Heart

Nurse well-being

Spring Clean Your Home and Heart

Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy

Cancer research

Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy

Oncology Drug Reference Sheet: Belumosudil

Drug Reference Sheet

Oncology Drug Reference Sheet: Belumosudil

FDA Approves Azacitidine for Newly Diagnosed Juvenile Myelomonocytic Leukemia

U.S. Food and Drug Administration (FDA)

FDA Approves Azacitidine for Newly Diagnosed Juvenile Myelomonocytic Leukemia

E-Cigarettes Increase Risk of Lung and Bladder Cancer More Than Traditional Cigarettes

Cancer research

E-Cigarettes Increase Risk of Lung and Bladder Cancer More Than Traditional Cigarettes

Use the Evidence to Integrate Ethics in Teleoncology Care

Oncology nurse-patient relationship

Use the Evidence to Integrate Ethics in Teleoncology Care

Don’t Ask Patients About Their Symptoms—Have Them Tell You

Symptom management

Don’t Ask Patients About Their Symptoms—Have Them Tell You

AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers

Cancer research

AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers

Back to Top ▲